RepSox
SIGMA/R0158 - ≥98% (HPLC)
Synonym: E-616452; 2-
CAS Number: 446859-33-2
Empirical Formula (Hill Notation): C17H13N5
Molecular Weight: 287.32
MDL Number: MFCD09037561
Linear Formula: C17H13N5
Product Type: Chemical
| assay | ≥98% (HPLC) |
| form | solid |
| InChI | 1S/C17H13N5/c1-11-4-2-5-1 |
| InChI key | LBPKYPYHDKKRFS-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cc1cccc(n1)-c2n[nH]cc2-c3 |
| solubility | DMSO: >20 mg/mL |
| storage temp. | 2-8°C |
| Application: | RepSox has been used as an inhibitor of autophosphorylation of the transforming growth factor β type I receptor kinase (ALK5). It has also been used as a basal media component for culturing human Pluripotent stem cells. |
| Biochem/physiol Actions: | RepSox inhibits osteoclast differentiation, resorption in bone tissues and ovariectomy (OVX)‐induced osteoporosis (OP) through repression of the SMAD family member 3 (Smad3) and c-Jun N-terminal kinase (JNK) pathway/ activator protein 1 (AP-1) pathways. |
| Biochem/physiol Actions: | RepSox Inhibits TGF-beta receptor signaling. |
| Biochem/physiol Actions: | RepSox Inhibits TGF-beta receptor signaling. Retroviral transduction of Sox2, Oct4, and Klf4 genes results in direct reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | T |
| Risk Statements | 25 |
| Safety Statements | 45 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 51111800 |

